In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we discuss my lastest Editor’s Letter that appeared in the May issue of MPO, The Power of My Voice (click to read that Letter). In it, I provide my own opinions on the technology, how it’s being used in medical devices, and how it could potentially be used for healthcare in the future. I also offer an example of a partnership between the Mayo Clinic and an Israeli company, Beyond Verbal, where voice-enabled technology is being tested as a diagnostic tool for coronary artery disease. I don’t, however, get into the regulatory concerns and potential pitfalls of voice-enabled technology so we discussed it on this episode of Mike on Medtech. Sharing his own thoughts on this topic, Mike Drues delves into the FDA’s oversight of voice-enabled medical devices and how they are treated.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Once you’ve had a chance to listen to the podcast, if you have any questions or comments you’d like us to discuss or share with other Mike on Medtech listeners about this topic or any other topic we’ve addressed, or you have a suggestion for a future topic for us to cover, email me at [email protected] and we’ll try to respond in an upcoming Mike on Medtech podcast.

Send us a text

For more medtech news and information, visit https://www.mpomag.com.